Same and Hypercementosis - a phase IV clinical study of FDA data
Summary:
We study 78 people who take Same (same) or have Hypercementosis. No report of Hypercementosis is found in people who take Same.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Same?
Same has active ingredients of same. It is often used in depression. eHealthMe is studying from 65 Same users. Check the latest studies of Same.
What is Hypercementosis?
Hypercementosis (excessive deposition of cementum on tooth roots) is found to be associated with 6 drugs and 2 conditions by eHealthMe. Check the latest studies of Hypercementosis.
No report is found.
Do you take Same and have Hypercementosis?
- Check whether Hypercementosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Same:
- Same (65 reports)
Hypercementosis treatments and more:
- Hypercementosis (13 reports)
How severe was Hypercementosis and when was it recovered:
Expand to all the drugs that have ingredients of same:
Browse all side effects of Same:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hypercementosis:
Browse all the conditions that are associated with Hypercementosis:
How the study uses the data?
The study uses data from the FDA. It is based on same (the active ingredients of Same) and Same (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vitamins and Throat Irritation for Women aged 30-39 - a second ago
- Novolog and Zanaflex drug interactions for women aged 40-49 - 2 seconds ago
- Could Modafinil cause Canker Sores? - 4 seconds ago
- Drug interactions of Rizatriptan Benzoate and Revlimid - 6 seconds ago
- Decreased Activity and drugs of ingredients of lorazepam - 8 seconds ago
- Formoterol Fumarate and Blood Pressure Increased for Men aged 50-59 - 15 seconds ago
- Formoterol Fumarate and Htn for Men aged 50-59 - 15 seconds ago
- Formoterol Fumarate and Hypertension for Men aged 50-59 - 16 seconds ago
- Formoterol Fumarate and Hbp for Men aged 50-59 - 16 seconds ago
- Formoterol Fumarate and Blood Pressure - High for Men aged 50-59 - 16 seconds ago